(Q22252885)

PubMed

7 February 2023

Nuria Caballol

1

Nuria

Caballol

1 reference

PubMed

18175397

7 February 2023

Maria J Martí

series ordinal

2

author given names

Maria J

author last names

Martí

1 reference

PubMed

18175397

The association of incident dementia with mortality in PD.

7 February 2023

language of work or name

English

0 references

publication date

2007

0 references

published in

Movement Disorders

0 references

volume

22

0 references

issue

S17

0 references

page(s)

S358-S366

0 references

cites work

1 reference

Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

21 January 2018

1 reference

Cognitive impairments associated with early Parkinson's disease.

21 January 2018

1 reference

Risk of dementia in Parkinson's disease: a community-based, prospective study.

21 January 2018

1 reference

A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease.

21 January 2018

1 reference

Motor impairment in PD: relationship to incident dementia and age.

21 January 2018

1 reference

Antecedent clinical features associated with dementia in Parkinson's disease

21 January 2018

1 reference

Neuropsychological characteristics of preclinical dementia in Parkinson's disease.

21 January 2018

1 reference

Neuropsychological differences between the dementias of Alzheimer's and Parkinson's diseases

21 January 2018

1 reference

Albendazole therapy for giant subarachnoid cysticerci.

21 January 2018

1 reference

Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease.

21 January 2018

1 reference

The occurrence of depression in Parkinson's disease. A community-based study.

21 January 2018

1 reference

Development of daytime somnolence over time in Parkinson's disease

21 January 2018

1 reference

Cognitive change following MPTP exposure.

21 January 2018

1 reference

Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group.

21 January 2018

1 reference

A clinicopathologic study of 100 cases of Parkinson's disease

21 January 2018

1 reference

Atypical antipsychotics in Parkinson-sensitive populations

21 January 2018

1 reference

The Frequency and Associated Risk Factors for Dementia in Patients With Parkinson's Disease

21 January 2018

1 reference

7 January 2021

Parkinson disease neuropathology: later-developing dementia and loss of the levodopa response

1 reference

7 January 2021

Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study

1 reference

7 January 2021

Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

1 reference

7 January 2021

The rate of cognitive decline in Parkinson disease.

1 reference

7 January 2021

Prognosis of Parkinson Disease

1 reference

7 January 2021

Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease

1 reference

7 January 2021

Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study

1 reference

7 January 2021

Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients

1 reference

7 January 2021

Combined effect of age and severity on the risk of dementia in Parkinson's disease

1 reference

7 January 2021

Basal forebrain neurons in the dementia of Parkinson disease

1 reference

7 January 2021

Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra

1 reference

7 January 2021

A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia.

1 reference

7 January 2021

Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia

1 reference

7 January 2021

Olanzapine treatment for dopaminergic-induced hallucinations

1 reference

7 January 2021

Memory and executive function impairment predict dementia in Parkinson's disease.

1 reference

7 January 2021

Deficit of verb generation in nondemented patients with Parkinson's disease.

1 reference

7 January 2021

What causes mental dysfunction in Parkinson's disease?

1 reference

7 January 2021

Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia.

1 reference

7 January 2021

Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.

1 reference

7 January 2021

A systematic review of prevalence studies of dementia in Parkinson's disease

1 reference

7 January 2021

Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.

1 reference

7 January 2021

Cognitive deficits in Parkinson's disease

1 reference

7 January 2021

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

1 reference

7 January 2021

Cognitive dysfunction and dementia in Parkinson's disease

1 reference

7 January 2021

Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions

1 reference

7 January 2021

Normal release from proactive interference in untreated patients with Parkinson's disease

1 reference

7 January 2021

Cognitive function in Parkinson's disease: From description to theory

1 reference

7 January 2021

'Lewy body disease': clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia.

1 reference

7 January 2021

Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease

1 reference

7 January 2021

Verbal memory in non-demented patients with idiopathic Parkinson's disease.

1 reference

7 January 2021

Cognitive and vestibulo-proprioceptive components of spatial ability in Parkinson's disease.

1 reference

7 January 2021

Cortical cholinergic deficit in mentally impaired Parkinsonian patients

1 reference

7 January 2021

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

7 January 2021

Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients

1 reference

7 January 2021

Dementia associated with Parkinson's disease

1 reference

7 January 2021

Cognitive impairment in Parkinson's disease

1 reference

7 January 2021

Rivastigmine for dementia associated with Parkinson's disease

1 reference

7 January 2021

beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease

1 reference

7 January 2021

Cognitive deficits in the early stages of Parkinson's disease.

1 reference

7 January 2021

Frontal lobe dysfunction in Parkinson's disease. The cortical focus of neostriatal outflow

1 reference

7 January 2021

Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability

1 reference

7 January 2021

Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors.

1 reference

7 January 2021

The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study

1 reference

7 January 2021

Dopamine and cognitive function

1 reference

7 January 2021

Dementia in Parkinson's disease: cause and treatment

1 reference

7 January 2021

Quetiapine and clozapine in parkinsonian patients with dopaminergic psychosis

1 reference

7 January 2021

Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia.

1 reference

7 January 2021

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

1 reference

7 January 2021

Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease

1 reference

7 January 2021

Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.

1 reference

7 January 2021

Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease.

1 reference

7 January 2021

Diffuse neurofibrillary tangles with calcification: a new presenile dementia

1 reference

7 January 2021

Neuropsychological prediction of dementia in Parkinson's disease

1 reference

7 January 2021

Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study

1 reference

7 January 2021

Lewy body cortical involvement may not always predict dementia in Parkinson's disease

1 reference

7 January 2021

Neuropsychological profile of patients with Parkinson's disease without dementia.

1 reference

7 January 2021

Cognitive Predictors of Dementia in Parkinson’s Disease: A Community-Based, 4-Year Longitudinal Study

1 reference

7 January 2021

Fluctuations in attention: PD dementia vs DLB with parkinsonism

1 reference

7 January 2021

Visuospatial impairment in Parkinson's disease

1 reference

7 January 2021

Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease

1 reference

7 January 2021

Identifiers

DOI

10.1002/MDS.21677

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

18175397

1 reference

Consolidated OpenCitations Corpus – April 2017